Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2+ Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab [0.03%]
新辅助化疗联合曲妥珠单抗和帕妥珠单抗治疗HER2阳性乳腺癌患者术前影像学肿瘤大小与术后病理肿瘤大小的相关性分析
Veronica Falcone,Elisabeth Reiser,Lenka Grula et al.
Veronica Falcone et al.
Background: Neoadjuvant chemotherapy (NAC) in combination with anti-HER2 treatment is standard of care in patients with early HER2 positive breast cancer. Preoperative radiological evaluation is mandatory for defining the...
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy [0.03%]
新辅助化疗后病理阴性的临床阳性腋窝淋巴结乳腺癌患者的区域淋巴结照射
Ashley Schlafstein,Yuan Liu,Subir Goyal et al.
Ashley Schlafstein et al.
Introduction: Neoadjuvant chemotherapy (NAC) is increasingly used for operable breast cancer (BC). Appropriate radiation therapy (RT) fields (ie, whole breast [WB] ± regional nodal irradiation [RNI]) in patients who were...
Hanjie Mo,Khalid A Jazieh,Daria Brinzevich et al.
Hanjie Mo et al.
This article reviews the available literature that describes the incidence, diagnosis, mechanism, symptoms, and management of pulmonary toxicity induced by radiation therapy and current systemic medications used to treat breast cancer. An e...
Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment [0.03%]
自动乳腺全容积成像作为新辅助治疗乳腺癌疗效监测工具的可行性研究——对比手持超声检查方法
Maria Eleni Hatzipanagiotou,Deborah Huber,Valeria Gerthofer et al.
Maria Eleni Hatzipanagiotou et al.
Introduction: The Invenia Automated Breast Ultrasound Screening (ABUS) is indicated as an adjunct to mammography for breast cancer screening in asymptomatic women with high-density breast tissue. ABUS provides time-effici...
Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery [0.03%]
利用多枚放射性粒子置入实现乳腺癌保乳手术阴性切缘的临床研究
Mary S Guirguis,Cristina Checka,Beatriz E Adrada et al.
Mary S Guirguis et al.
Introduction: Breast conservation surgery (BCS) is the treatment of choice for unifocal, early-stage breast cancer. The ability to offer BCS to a wider subset of patients, including those with multifocal/multicentric canc...
Berta Obispo,Jacobo Rogado,Miguel Ángel Lara Álvarez
Berta Obispo
Aerobic Fitness is a Predictor of Body Composition in Women With Breast Cancer at Diagnosis [0.03%]
体能是诊断乳腺癌女性身体组成的影响因素
Henrique Ims Bortolozo,Sophie Derchain,Felipe C Vechin et al.
Henrique Ims Bortolozo et al.
Background: The objective of this study was to investigate the relationship of aerobic fitness (AF) at diagnosis, before treatment and its relationship with body composition, physical function, lipidic profile, comorbidit...
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer [0.03%]
氯喹联合紫杉烷类药物治疗蒽环类耐药的晚期或转移性乳腺癌患者疗效和安全性的II期研究
Kartik Anand,Polly Niravath,Tejal Patel et al.
Kartik Anand et al.
Introduction: Chemotherapy eliminates most of the cancer cells except those with potential for self-renewal and tumor initiation, called cancer stem cells (CSCs). Chloroquine, through bioinformatics, was found to be a pot...
Clinical Trial
Clinical breast cancer. 2021 Jun;21(3):199-204. DOI:10.1016/j.clbc.2020.09.015 2021
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer [0.03%]
苹果酸舒尼替尼联合紫杉醇周疗序贯多西他赛和口服环磷酰胺+G-CSF新辅助治疗局部进展期或炎性乳腺癌的Ⅱ期临床研究
Lynn Symonds,Isaac Jenkins,Hannah M Linden et al.
Lynn Symonds et al.
Introduction: Neoadjuvant chemotherapy is standard treatment for locally advanced breast cancer (LABC) or inflammatory breast cancer (IBC). We hypothesized that adding sunitinib, a tyrosine kinase inhibitor with antitumor...
Clinical Trial
Clinical breast cancer. 2022 Jan;22(1):32-42. DOI:10.1016/j.clbc.2021.05.009 2022
S Ophie Guillerm,Edwige Bourstyn,Ramona Itti et al.
S Ophie Guillerm et al.
Purpose: To evaluate outcomes and postoperative toxicities after intraoperative radiotherapy (IORT) in elderly women. Population: Women...